Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Accelovance, a global contract research organization has announced the completion of enrollment and delivery of the final locked database to Heron Therapeutics for the Phase 3 trial of its 5-HT3 receptor antagonist product candidate SUSTOL®.
read more
Ajinomoto Bio-Pharma Services has announced the launch of AJILITY™, a flexible and agile drug product manufacturing platform.
read more
Wednesday, September 13, 2023
Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h ...
read more
goBalto announced its partnership with Citeline to integrate data from Citeline's intelligence platforms, including Trialtrove and Sitetrove, with goBalto's Select.
read more
AMRI (NASDAQ: AMRI) today announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y. site to other sites within AMRI and will cease operations in Syracuse by the end of June 2014. The actions ...
read more
Wednesday, September 27, 2017
Crown Bioscience announced the appointment of Laurie Heilmann as Chief Business Officer.
read more
Thursday, November 30, 2017
Catalent and Vaccinex will develop an ADC using Catalent’s SMARTag conjugation platform and GPEx cell line engineering technologies, and Vaccinex’s ActivMAb technology.
read more
Frontage Laboratories announces the acquisition of Concord Biosciences, formerly known as Ricerca Biosciences, a preclinical CRO located near Cleveland, Ohio.
read more
Azenta opened its new China headquarters in Suzhou, which serves as the hub for operations in the Asia Pacific.
read more
Friday, December 28, 2018
Dr. Reddy’s announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets, a therapeutic equivalent generic version of Renvela.
read more
Tuesday, December 10, 2019
PHARMASEAL has won Start-Up of the Year in the 2019 Medilink East Midlands Business Awards.
read more
Acerus has reached a mutual agreement with Innovus to terminate the exclusive distributor and license agreement granting Acerus the rights to commercialize UriVarx® in Canada.
read more
Emmes announced that it provided the data and statistical analysis support for the Phase 1 clinical trial of the investigational COVID-19 vaccine mRNA-1273.
read more
On May 19-21 in Boston, clinical trial sponsors, CROs, sites and leaders from around the world will gather at the inaugural CenterWatch Forum on Optimizing Clinical Research Performance conference to discuss collaboration and innovation within a ...
read more
Wednesday, March 29, 2017
Warp Drive Bio, Inc., a life sciences company developing therapeutics that exploit the molecules and mechanisms of nature, has announced a collaboration with GSK, which combines Warp Drive’s Small Molecule-Assisted Receptor Targeting (SMART™) ...
read more